Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05587582 · ClinicalTrials.gov registry record
Behavioral Parenting Skills As A Novel Target for Improving Pediatric Medication Adherence
A clinical trial, sponsored by Roswell Park Cancer Institute.
- Completed
- Registry status
- 51
- Enrollment target
NCT05587582: Completed study, sponsored by Roswell Park Cancer Institute.
NCT05587582 is a clinical trial that has completed, run by Roswell Park Cancer Institute. The registered enrollment target is 51 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05587582 has completed, sponsored by Roswell Park Cancer Institute.
- COMPLETED
- Registry status
- 51 participants
- Enrollment target
Study Summary
This study observes behavioral parenting skills to see whether it could be a novel target for improving pediatric medication adherence. This study may help researchers better understand the challenges parents face when giving their young child with an illness medicine at home and learn about various factors related to medication compliance in young children
Primary Outcome
Association between ingestion of medication and the absence or presence of each of the Observations of parents and children as they interact with each other during medication administration. Interactions will be coded by trained observers.
Interventions
- OTHER Survey Administration
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2022-09-01 |
| Est. Completion | 2025-01-07 |
What the finished NCT05587582 record still lists
NCT05587582 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 51 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Survey Administration is the first listed.
NCT05587582 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05587582 about?
NCT05587582 is a clinical study titled "Behavioral Parenting Skills As A Novel Target for Improving Pediatric Medication Adherence". This study observes behavioral parenting skills to see whether it could be a novel target for improving pediatric medication adherence. This study may help researchers better understand the challenges parents face when giving their young child with an illness medicine at home and learn about various...
What is the current status of trial NCT05587582?
This trial is currently completed. The enrollment target is 51 participants. The study started on 2022-09-01. Estimated completion is 2025-01-07.
What interventions are being tested in trial NCT05587582?
The interventions under investigation include: Survey Administration (OTHER).
Who is sponsoring clinical trial NCT05587582?
This trial is sponsored by Roswell Park Cancer Institute, which has 365 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02701153 · 51 participants · NA
Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort
- NCT03663790 · 51 participants · NA
Effects of Gait Retraining on Lower Extremity Biomechanics
- NCT03874052 · 51 participants · Phase 1
Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
- NCT04704661 · 51 participants · Phase 1
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI